Community protocol · 5-Amino-1MQ
A complete substance profile covering documented community themes, scientific context and explicit safety boundaries. Missing or non-standardised data are not replaced with estimates.
Also known as: 5-amino-1-methylquinolinium · NNMT inhibitor
Sources checked: 27 August 2026
This page documents and evaluates online community information. It is not medical or therapeutic advice, individual counselling or an invitation to use Ipamorelin. It is not approved for the uses described here.
No medical, therapeutic or individual recommendation. Information is provided without warranty and used at your own risk. No liability for calculation errors, use, contamination, interactions or consequences.
Quick context
Not a peptide. Studied preclinically in fat-cell and energy metabolism; robust human efficacy and safety data are lacking.
This entry is not a single peptide, or its use depends on diagnosis, product form or composition. A blanket peptide dose would be misleading.
Amounts, timing and cycles
This entry is not a single peptide, or its use depends on diagnosis, product form or composition. A blanket peptide dose would be misleading.
Different amounts circulate online; no regulator-confirmed safe or effective dose exists.
Profile evidence level: preclinical.
Community claims about time of day, fasting windows or training intervals are not validated clinical standards.
No individual recommendation.
Cycles and breaks are community constructs and do not prevent adverse effects or unknown long-term consequences.
No individual recommendation.
External community reference available
The external page is used only to document community claims. Advertising and affiliate material were excluded; its content is neither approval nor proof of quality.
Open community sourceReconstitution and U-100 conversion
Reconstitution is not generally applicable to this substance or product class. Form, concentration and handling must come from the exact authentic product and its official labelling.
Reconstitution is not generally applicable to this substance or product class. Form, concentration and handling must come from the exact authentic product and its official labelling.
Mechanism and research questions
5-Amino-1MQ is classified as “Experimental small-molecule inhibitor of nicotinamide N-methyltransferase”. Not a peptide. Studied preclinically in fat-cell and energy metabolism; robust human efficacy and safety data are lacking. This describes the investigated pathway but does not validate a community use, amount, route or combination.
This studies how inhibiting a metabolic enzyme called NNMT could affect the energy expenditure of fat cells, similar to removing a brake block. Enzyme activity and metabolic markers are measured in cell models.
This studies how fat cells store, release, and burn energy, similar to observing how a storage tank fills and empties. Researchers typically measure fat cell size, enzyme activity, and energy expenditure in cell or animal models.
Researchers study how cells produce and use energy, particularly through the mitochondria, similar to measuring how efficiently an engine burns fuel. Typical measures include oxygen consumption and energy output in cell models.
These themes describe discussion and vendor claims. They do not prove benefit, safety, product identity or suitable use.
In these forums, users compare their own weight trajectories, side effects, and perceived appetite changes between different products. Before-and-after photos and personal timelines are often shared. Such anecdotes and vendor marketing claims are not scientific proof of efficacy.
Users compare self-assembled combinations of peptides aimed at influencing ageing processes or energy levels, often based on blood tests or subjective wellbeing scales. Personal self-experiments and marketing promises do not replace controlled long-term human studies.
Discussion covers which vendors are seen as more trustworthy and how purity test results differ between batches. Such community assessments are based on limited samples and do not replace independent lab testing of each individual batch.
Adverse effects and risk boundaries
Exclusion groups and professional assessment
Monitoring and laboratory markers
Evidence boundary
Robust human efficacy and safety have not been demonstrated.
Published evidence
Available data come mostly from animal or cell models; robust human efficacy and safety data are lacking.
5-Amino-1MQ is not a peptide but a small-molecule NNMT inhibitor, unlike peptide-based metabolic candidates.
Storage and stability
Troubleshooting and error sources
Regulatory status and WADA
No FDA- or EMA-approved medicinal product; efficacy and safety are not established.
WADA 2026
The atlas has no explicit WADA flag for this profile. That does not automatically mean every form, route or related class is permitted in sport.
WADA — 2026 Prohibited ListComparisons and related profiles
Combinations / stacks
Frequently asked questions
No. This page separates approved product information, study protocols and community information. No number or calculator is an individual dosing recommendation.
No. It only converts mass, volume and syringe scale. It cannot check identity, purity, sterility, stability, solvent or medical suitability.
Safety of a combination cannot be inferred from a single-substance profile. Overlapping pathways, medicines and undefined blends can increase risk.
For approved medicines, the current prescribing information and treating professional control. For research substances, conflict shows that no dependable self-use standard exists.
No. Anecdotes can generate questions but do not replace controlled studies, regulatory review, or identity and quality testing.
Sources and evidence layers
Primary sources and official registries take priority. The community reference is labelled separately.
